Option Exercise Fee. 3.1 In consideration for Bayer’s exercise of the Option according to Section 8 of the Collaboration Agreement with regard to the respective Lead Series and the execution of this Agreement, , and as consideration for the licenses granted by Recursion to Bayer under Section 2.1 of this Agreement, Bayer shall pay Recursion an “Option Exercise Fee” of [***] within [***] days after receipt of a correct invoice that is compliant with the Applicable Law.
Appears in 2 contracts
Samples: License Agreement (Recursion Pharmaceuticals, Inc.), License Agreement (Recursion Pharmaceuticals, Inc.)
Option Exercise Fee. 3.1 In consideration for Bayer’s exercise of the Option according to Section 8 of the Collaboration Agreement with regard to the respective Lead Series Development Candidate and the execution of this Agreement, , and as consideration for the licenses granted by Recursion to Bayer under Section 2.1 of this Agreement, Bayer shall pay Recursion an “Option Exercise Fee” of [***] within [***] days after receipt of a correct invoice that is compliant with the Applicable Law.
Appears in 2 contracts
Samples: License Agreement (Recursion Pharmaceuticals, Inc.), License Agreement (Recursion Pharmaceuticals, Inc.)